From Pfizer to CDMO start-up episode artwork

EPISODE · Mar 17, 2021 · 35 MIN

From Pfizer to CDMO start-up

from Molecule to Market: Inside the outsourcing space · host molecule2market

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gerry, covering:     The transition from two decades in Big Pharma to the entrepreneurial world of running a CDMO. Becoming known as the ‘lab down the hall’ for many clients with products in the clinical phase of development. The value of talking to people, networking and not being intimidated when starting out your own business. Consistently keeping your operational house in order in the face of increasing market demand. Raman has taken great pleasure in getting to know fellow Bostonian Gerry, since moving to the states. An accountant by trade, Gerry worked for Pfizer for eighteen years in corporate and research & development roles, both globally and onsite. Since founding Velesco back in 2007, he has led the steady growth of the company’s operations and its most recent expansions. A phenomenal networker, Gerry enjoys connecting people and communicating with people within the sector. Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gerry, covering:     The transition from two decades in Big Pharma to the entrepreneurial world of running a CDMO. Becoming known as the ‘lab down the hall’ for many clients with products in the clinical phase of development. The value of talking to people, networking and not being intimidated when starting out your own business. Consistently keeping your operational house in order in the face of increasing market demand. Raman has taken great pleasure in getting to know fellow Bostonian Gerry, since moving to the states. An accountant by trade, Gerry worked for Pfizer for eighteen years in corporate and research & development roles, both globally and onsite. Since founding Velesco back in 2007, he has led the steady growth of the company’s operations and its most recent expansions. A phenomenal networker, Gerry enjoys connecting people and communicating with people within the sector. Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

NOW PLAYING

From Pfizer to CDMO start-up

0:00 35:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Molecule to Market: Inside the outsourcing space?

This episode is 35 minutes long.

When was this Molecule to Market: Inside the outsourcing space episode published?

This episode was published on March 17, 2021.

What is this episode about?

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services. Your host, Raman Sehgal, discusses the...

Can I download this Molecule to Market: Inside the outsourcing space episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!